IMMJ Systems – a provider of electronic document management solutions for the NHS – has appointed a new CEO as the HealthTech specialist gears up for further expansion.
Experienced business leader Jon Pickering has joined the firm with over two decades of technology and telecoms expertise, from high-growth healthcare and software as a service (SaaS) environments.
His appointment coincides with the promotion of head of software engineering Andrew Leeks – who now assumes the role of CTO – and former head of transformation Lisa Harris, who has advanced to COO.
Graham Ridgway – an established non-executive director – remains the company chairman, having been appointed to the position in January 2021; Jennie Costello continues in her role as CFO and Jamie Hall maintains his focus as head of sales.
Chelmsford-headquartered IMMJ is currently working with 20 UK NHS Trusts. Customers of its MediViewer product include Imperial College Healthcare NHS Trust, The Hillingdon Hospitals NHS Foundation Trust and integrated health and care service provider for the Isle of Man Government, Manx Care.
IMMJ already securely handles over 1 billion healthcare images for UK patients.
Under the leadership of the new executive team, IMMJ has ambitions to acquire 30 additional customers by the end of the 2026 financial year, which will see annual recurring revenue rise to £6m.
“In relative terms, IMMJ remains a young HealthTech firm, having been established in only 2015. However, backed by investment from Foresight – and with an incredible pedigree of committed talent from the healthcare sector – the business has grown quickly,” said Pickering.
“It was apparent last year that a new commercial strategy was required – not only to drive the organisation forward to reach its full potential, but to better enable the rapid digitisation of clinical content for use at the point of care.
“This is a complex ecosystem – not least because of red tape surrounding funding, and the marked digital maturity differences from one Trust to the next. However, the succession plan for IMMJ – which saw the four founding directors fully exit the business and a new exec team take shape – means we are ambitious about our plans for the years ahead.”